What We’re Watching: 2025 First Quarter Earnings Results
A look at how the market's 2024 finish, resurgent M&A volume and the potential impact of tariffs on the orthopedic industry. Apr 22, 2025
J&J MedTech Starts Slow in 2025, Eyes Second Half
One-time events and competitive pressures created a slower start to 2025 for J&J MedTech's orthopedic sales. Apr 17, 2025
Smith+Nephew Faces Crucial Test in 2025
Smith+Nephew's 12-Point Plan is working and driving improved performance for the company. But is it working fast enough? Apr 09, 2025
The State of Enabling Technology in 2025
We expect healthy demand, more competitive pressure at the top of the market and a focus on creating optionality within tech portfolios. Mar 11, 2025
Digital and Obio Assets in Greater Demand for M&A
Over the last four years, spine M&A volume declined significantly while digital and orthobiologic assets saw increased activity. Mar 10, 2025
Orthopedic Executives Reflect on Transformational 2024
Selected comments from the leaders of top orthopedic companies as they reported fourth quarter 2024 earnings. Mar 05, 2025
Enovis Completes Transformational Year; Hits $1 Billion in Recon
The company grew in the high single digits in 2024 as it made significant progress integrating its Lima acquisition. Feb 28, 2025
ATEC Positioned for Another Big Leap in 2025
The company grew nearly 27% in 2024 as its technology and procedural approach continued to compel surgeon adoption in the spine market. Feb 28, 2025
Orthofix Medical to Focus on Most Profitable Opportunities
The company grew in the high single digits in 2024 and made moves to prioritize its most profitable growth opportunities in 2025. Feb 27, 2025
Smith+Nephew Improves, Faces Mounting Headwinds in China
The company's 12-Point Plan is producing results, but China will remain a major drag on sales and profitability in 2025. Feb 27, 2025
